Vapotherm (VAPO) Plunges 40% On Disappointing Earnings
Vapotherm (VAPO) fell 40% today, shortly after announcing disappointing Q3 FY’22 earnings.
Total revenue was $13.5 million, which is down 65% from the same period last year and missed the consensus estimate of $16.54 million. VAPO also posted a wider EPS loss than expected.
The Company is currently evaluation various capital-raising ventures while continuing its path to profitability, which also could have contributed to the share price drop.
Vapotherm is a member of the PRISM MedDevices Index, which fell 1.8% for the day.
For more information on Vapotherm’s earnings, see here.